Overview

Webcast ImageWebcast
Clovis Oncology ASCO Investor Event (Live)
05/31/15 at 7:00 p.m. ET
Clovis Oncology ASCO Investor Event
Sunday, May 31, 2015 7:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs target specific subsets of cancer, and we seek to simultaneously develop, with partners, companion diagnostics that direct our product candidates to the patients most likely to benefit from their use. We believe this approach to personalized medicine – More >>

Stock Chart
Stock chart for: 03NA000000CLVS
Stock Quote
CLVS (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$90.60
Change (%) Stock is Down 3.2 (3.41%)
Intraday High$93.44
Intraday Low$89.55
Volume637,114
Data as of 05/28/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle  
05/13/15Clovis Oncology Announces Data Presentations at 2015 ASCO Annual Meeting
Rociletinib oral presentation on Sunday, May 31 to update TIGER-X clinical data in heavily pretreated, advanced EGFR-mutant lung cancer patients, including in plasma-genotyped T790M-positive patients Rucaparib oral presentation on Monday, June 1 to include outcomes data from full ARIEL2 part one population of ~200 women with advanced ovarian cancer Rociletinib rolling NDA submission for EGFR-mutant lung cancer ... 
Printer Friendly VersionDownload PDF
05/06/15Clovis Oncology Announces First Quarter 2015 Operating Results
Rociletinib (CO-1686) rolling NDA submission for EGFR-mutant lung cancer expected to commence in June, and complete by July/August Launch planning underway for potential late 2015 U.S. launch of rociletinib Phase 1/2 rociletinib data published in April 30 issue of the New England Journal of Medicine Rucaparib granted Breakthrough Therapy designation in April NDA filing f... 
Printer Friendly VersionDownload PDF
04/23/15Clovis Oncology to Announce First Quarter 2015 Financial Results and Host Webcast Conference Call on May 6
BOULDER, Colo.--(BUSINESS WIRE)--Apr. 23, 2015-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2015 financial results on Wednesday, May 6, 2015, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET that day to discuss the company’s results in greater detail. The conference call is being webcast and can be accessed from the Clovis O... 
Printer Friendly VersionDownload PDF
Upcoming EventsMore >>
DateTitle
05/31/15
7:00 p.m. ET
Clovis Oncology ASCO Investor Event
Receive Email AlertsEmail Alert Icon
Sign up to receive email alerts whenever Clovis Oncology, Inc. posts new information to the site. Just enter your email address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.